Connect with us

Hi, what are you looking for?


Promoting ethical behavior in the pharma industry


Unethical behavior negatively impacts business performance, reputation, and access to funding and financing. It is a liability for businesses, said the Asia-Pacific Economic Cooperation (APEC).  

According to an APEC study titled “The Benefits of Embracing Ethical Business Conduct,” businesses that deploy dishonest approaches often do so to fulfill their short-term financial objectives. In the long term, however, the said conduct will adversely impact the business to a greater extent than the initial advantages obtained. It said that dishonest business practices can later on lead to increased costs. 

On the other hand, ethical behavior results in desirable business outcomes. The same APEC reference cited a study which found that an increase in the corporate value index is associated with the firm’s performance. Moreover, the benefits of an ethical reputation can also have a competitive advantage as a company distinguishes itself from its competitors. It added that companies that have strong, values-based corporate culture showed improved employee engagement, and increased overall positive reputation. 

In the healthcare community, unethical behavior hurts not just businesses. It also brings harm to patients and deprives them of quality and appropriate healthcare they deserve. Ethical interactions, meanwhile, help ensure that medical decisions are made in the best interests of patients. They also level the playing field and encourage robust competition in the industry. 

With this, the Pharmaceutical and Healthcare Association of the Philippines (PHAP) ratified its own Code of Practice, an internationally aligned Code that is a requirement for PHAP membership. The Code is implemented through an independent Ethics Committee and cascaded to PHAP members through a pioneering module called the Integrity and Proficiency Program for the Pharmaceutical Sector (IPPS). The IPPS, registered under the Professional Regulation Commission, offers science-related information and provides modules on laws and codes that must guide all interactions with healthcare professionals, the government, and patients, among others. 

As a member of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), PHAP fully subscribes to the IFPMA Ethos. The Ethos has overarching values namely trust, care, fairness, respect and honesty. This set of core values and principles helps ensure that their interactions with healthcare professionals and the broader health community are appropriate and in line with the expectations of the society. The Ethos underpins the rules and provides a framework to behave with integrity no matter how testing the circumstances are. 

The Philippine government has achieved milestones when it comes to the campaign for integrity in the healthcare community. In 2011, the Mexico City Principles for Voluntary Codes of Business Ethics for the Biopharmaceutical Sector was endorsed by heads of states of APEC member economies, including the Philippines. In interacting with healthcare professionals and other stakeholders, PHAP member companies are guided by the six Mexico City Principles. 

The first principle is healthcare and patient focus which means that everything we do is intended to benefit patients. The second principle is integrity which means dealing ethically, honestly and respectfully in everything we do. 

Third is independence which means to respect the need for autonomous decision-making of all parties, free from improper influence. Fourth is legitimate intent which means everything we do is for the right reasons, is lawful, and aligns with the spirit and the values of these Principles. Fifth is transparency which means a general willingness to be open about our actions while respecting legitimate commercial sensitivities and intellectual property rights. Finally, accountability means a willingness to be responsible for our actions and interactions. 

The Philippine Food and Drug Administration also adopted and implemented the Mexico City Principles in September 2013. The Department of Health which created a Committee for the Creation and Adoption of the Mexico City Principles and Kuala Lumpur Principles for Medical Device Sector Codes of Business Ethics, must also be commended for pushing the integrity campaign forward. 

In accordance with the Nanjing Declaration to Promote Ethical Environments in the Medical Device and Biopharmaceutical Sectors (2014–2020), PHAP is also working with the government, healthcare professionals, and non-government organizations (NGOs) — in particular, patient organizations — to promote ethical environments in the medical device and biopharmaceutical sectors. 

Ethical principles are universal and reinforce Filipino values. Because of the unique role of ethical behavior in positively affecting the health and lives of patients, the pharmaceutical industry must always be committed to ethical behavior at all times. 

Teodoro B. Padilla is the executive director of the Pharmaceutical and Healthcare Association of the Philippines (PHAP), which represents the biopharmaceutical medicines and vaccines industry in the country. Its members are at the forefront of research and development efforts for COVID-19 and other diseases that affect Filipinos. 

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



PHILIPPINE STAR/ MICHAEL VARCAS WASHINGTON D.C. — The United States is seeking to form a coalition of countries to drive negotiations on a global...


Buildings are seen along EDSA in Quezon City. — PHILIPPINE STAR/ MIGUEL DE GUZMAN By Diego Gabriel C. Robles  THE WORLD BANK (WB) upgraded...


Heavy traffic is seen on the southbound lane of EDSA in Cubao, Quezon City. — PHILIPPINE STAR/ MIGUEL DE GUZMAN THE PHILIPPINE auto industry’s...


REUTERS THE BANGKO SENTRAL ng Pilipinas (BSP) may deliver a second off-cycle rate hike in early November when the US Federal Reserve is expected...


Vendors arrange their goods at a public market in Manila. — PHILIPPINE STAR/ RUSSEL A. PALMA THE ASIAN Development Bank (ADB) is planning to...

Editor’s Pick

With the reversal of the 1.25% rise in National Insurance Contributions happening on the 6th of November, employers across the nation have an opportunity...

You May Also Like


BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...


KARASOLAR.COM TENA, Ecuador — Ecuador’s rainforest Achuar people say their ancestors long dreamed of a “fire canoe” or “electric fish” that would let them...


REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...


COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.